Cardiac dysfunction in sepsis: new theories and clinical implications.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Prognostic value of troponins in sepsis: a meta-analysis.Intensive care medicine · 2013
   Pooled it
2. Integrated analysis of multi-omics data reveals T cell exhaustion in sepsis.Frontiers in immunology · 2023
   Article
3. Prognostic tools for elderly patients with sepsis: in search of new predictive models.Internal and emergency medicine · 2021
   Article
4. Role of TFEB Mediated Autophagy, Oxidative Stress, Inflammation, and Cell Death in Endotoxin Induced Myocardial Toxicity of Young and Aged Mice.Oxidative medicine and cellular longevity · 2016
   Article
5. Hyperdynamic left ventricular ejection fraction in the intensive care unit.Critical care (London, England) · 2015
   Article
6. Sepsis-induced cardiomyopathy: a review of pathophysiologic mechanisms.Heart failure reviews · 2010
   Review
7. Phospholemman: a novel cardiac stress protein.Clinical and translational science · 2010
   Review
8. Protein phosphatase 2A contributes to the cardiac dysfunction induced by endotoxemia.Cardiovascular research · 2009
   Article
9. Neurotensin increases mortality and mast cells reduce neurotensin levels in a mouse model of sepsis.Nature medicine · 2008
   Article
10. Cardiac morphological and functional changes during early septic shock: a transesophageal echocardiographic study.Intensive care medicine · 2008
    Article
11. Propofol infusion syndrome.Forensic science, medicine, and pathology · 2006
    Article
12. Takotsubo cardiomyopathy (acute left ventricular apical ballooning syndrome) occurring in the intensive care unit.Intensive care medicine · 2006
    Article
13. [Role of adrenomedullin in the pathogenesis and treatment of cardiovascular dysfunctions and sepsis].Der Anaesthesist · 2006
    Review
14. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.Clinical pharmacokinetics · 2006
    Review
15. The petrified heart in sepsis.Virchows Archiv : an international journal of pathology · 2005
    Article
16. Lactate concentration gradient from right atrium to pulmonary artery: a commentary.Critical care (London, England) · 2005
    Article
17. Identification, characterization, and gene expression profiling of endotoxin-induced myocarditis.Proceedings of the National Academy of Sciences of the United States of America · 2003
    Article
18. Matrix metalloproteinase inhibitors attenuate endotoxemia induced cardiac dysfunction: a potential role for MMP-9.Molecular and cellular biochemistry · 2003
    Article
19. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome.Intensive care medicine · 2003
    Review
20. Cardiac dysfunction in sepsis.Intensive care medicine · 1998
    Article

Corrections and comments

• Commented on by
  Cardiac dysfunction in sepsis.1998

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as